...
...

glaxosmithkline

Number of Covid-19 vaccines growing but volume of doses remains concern, says WHO Adviser

Over the past week, US media outlets reported that Pfizer is unlikely to meet its original supply targets for its vaccine against Covid-19, which is produced in conjunction with German firm BioNTech, due to supply chain issues.
Updated on Dec 12, 2020 06:46 am IST

Amid test data doubts, UK seeks temporary supply of AstraZeneca/Oxford vaccine

A test tube labelled with the vaccine is seen in front of AstraZeneca logo in this illustration taken on September 9.
Updated on Nov 27, 2020 06:01 pm IST

Sanofi reports positive animal test results for potential Covid-19 vaccine

There is no internationally-approved vaccine to protect against Covid-19, which has killed more than 1 million people around the world and triggered economic chaos.
Published on Oct 15, 2020 05:51 pm IST

GlaxoSmithKline CEO optimistic Covid-19 vaccine widely available in 2021

The group’s most advanced project is with French partner Sanofi and the two have said they hope to get approval for their candidate next year.
Published on Sept 30, 2020 08:55 am IST

Covid-19: What you need to know today

A reading of the protocols shows (warning: they make for heavy reading) that the J&J trial is the only one measuring the efficacy of the vaccine in preventing severe and critical cases of Covid-19.
Updated on Sept 25, 2020 02:40 am IST